News
Vical drops cancer therapy after trial failure, shares plunge |...
www.reuters.com
Vical Inc said it would stop development of its most advanced drug, cancer therapy Allovectin, after a late-stage trial failed to show that the treatment was...
Get set for repairs - The Economic Times
economictimes.indiatimes.com
If your building is over 30 years old, better make sure it undergoes the repair and maintenance that it requires, particularly as the monsoon arrives, says...
Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a...
newsroom.astellas.us
Astellas Pharma US, Inc. | News Room
Vical slashes staff in wake of vaccine setback - PharmaTimes
www.pharmatimes.com
Vical has eliminated almost 40% of its total workforce to conserve cash after the failure of its Allovectin immunotherapy for advanced melanoma. - News -...
sortiert nach Relevanz / Datum